Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taisho Pharma To Launch Cold Medicine Pabron Ace AX

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Taisho Pharmaceutical will launch Ace Ax, an over-the-counter cold medicine containing ambroxol hydrochloride, a pharmaceutical ingredient that leads to the easy expulsion of phlegm. Until recently, the use of blended ambroxol hydrochloride has been limited to prescription drugs; due to a relaxing of Japanese regulations, it became an OTC medicine. Effective for suppressing coughing, expelling phlegm and relieving sore throat symptoms, blended ambroxol hydrochloride has been used to treat the common cold. Two types of the medicine go on sale in Japan on Jan. 20, tablets and powder. (click here for more - may require subscription

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel